If you want to know who really controls Coherus Oncology, Inc. (NASDAQ:CHRS), then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the ...

List today: InfuSystems Holdings INFU: This rapidly growing healthcare services company that provides state-of-the-art ...

More and more providers are beginning to incorporate the new Practical Geriatric Assessment into their practices.

Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good day, everyone. Welcome to BeOne Q2 2025 Earnings Call Webcast. [Operator Instructions] At this time, I would like to turn the call over ...

During a live event, Jorge Monge, MD, discussed real-world evidence on the use of CAR T-cell therapy beyond the trial setting ...

During a livestream yesterday, OpenAI announced GPT-5, alongside a series of interface and usability improvements to its chatbot.

Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...

AC Milan has issued an official statement informing that Franco Baresi, club legend and current honorary vice president, ...

Leede Financial analyst Douglas Loe maintained a “Speculative Buy” rating and $11.00 target on Cardiol Therapeutics ...

Last year, researchers published an analysis that made grim reading for anyone hoping to live a much longer, healthier life ...

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...